These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6485796)

  • 41. Malignant mesothelioma: immunohistochemistry and DNA ploidy analysis as methods to differentiate mesothelioma from benign reactive mesothelial cell proliferation and adenocarcinoma in pleural and peritoneal effusions.
    Friedman MT; Gentile P; Tarectecan A; Fuchs A
    Arch Pathol Lab Med; 1996 Oct; 120(10):959-66. PubMed ID: 12046609
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Diagnostic value of impulse cytophotometric DNA histograms of malignant and non-malignant effusions (author's transl)].
    Schoen U; Noeske K
    Verh Dtsch Ges Pathol; 1973; 57():195-200. PubMed ID: 4142173
    [No Abstract]   [Full Text] [Related]  

  • 43. Differences in pleural fluid characteristics, white cell count and biochemistry of tuberculous and malignant pleural effusions.
    Liam CK; Lim KH; Wong CM
    Med J Malaysia; 2000 Mar; 55(1):21-8. PubMed ID: 11072486
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transforming growth factor activity in pleural and peritoneal effusions from cancer and non-cancer patients.
    Sairenji M; Suzuki K; Murakami K; Motohashi H; Okamoto T; Umeda M
    Jpn J Cancer Res; 1987 Aug; 78(8):814-8. PubMed ID: 3115927
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Positive effusion cytology as the initial presentation of malignancy.
    Monte SA; Ehya H; Lang WR
    Acta Cytol; 1987; 31(4):448-52. PubMed ID: 3604540
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of desmin and N-cadherin in effusion cytology: a comparative study using established markers of mesothelial and epithelial cells.
    Davidson B; Nielsen S; Christensen J; Asschenfeldt P; Berner A; Risberg B; Johansen P
    Am J Surg Pathol; 2001 Nov; 25(11):1405-12. PubMed ID: 11684957
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Complex assessment of the proliferation of epidermal and tumor cells in malignant skin lymphoma].
    Persina IS; Zabanova EV; Kotel'nikov VM; Kazantseva IA; Averbakh EV
    Vestn Dermatol Venerol; 1989; (10):4-7. PubMed ID: 2609746
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Significance of AgNOR count in differentiating malignant cells from reactive mesothelial cells in serous effusions.
    Sujathan K; Kannan S; Pillai KR; Chandralekha B; Amma NS; Nair MK
    Acta Cytol; 1996; 40(4):724-8. PubMed ID: 8693893
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Contribution of immunocytochemical marking of benign cells to the diagnosis of serous effusions].
    Gaulier A; Cava E; Chosia MC; Pore G; Marsan C
    Ann Pathol; 1986; 6(4-5):323-8. PubMed ID: 3814272
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression of intercellular adhesion molecule-1 (ICAM-1) by reactive mesothelial cells in pleural effusions.
    Mutti L; Piacenza A; Valenti V; Castagneto B; Betta PG
    Pathologica; 1993; 85(1100):725-8. PubMed ID: 7909596
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Triggering receptor expressed on myeloid cells-1 in pleural effusions: a marker of inflammatory disease.
    Liu CL; Hsieh WY; Wu CL; Kuo HT; Lu YT
    Respir Med; 2007 May; 101(5):903-9. PubMed ID: 17097866
    [TBL] [Abstract][Full Text] [Related]  

  • 52. P53-immunoreactive cells in benign and malignant effusions: diagnostic value using a panel of monoclonal antibodies and comparison with CEA-staining.
    Stoetzer OJ; Munker R; Darsow M; Wilmanns W
    Oncol Rep; 1999; 6(2):455-8. PubMed ID: 10023021
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cytologic diagnosis and chromosome analysis: sensitivity, specificity, accuracy and predictive value in malignant and benign pleural effusions.
    Giazza G; Cosimi MF; Lanero M; Rossi GP; Casagranda I
    Pathologica; 1990; 82(1077):33-40. PubMed ID: 2362783
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Cytological, biochemical and immunologic parameters of pleural effusions. Presentation of differences in relation to the nature of the effusion].
    Kruszewski J; Płusa T; Maleszka P
    Pneumonol Alergol Pol; 1991; 59(7-8):47-50. PubMed ID: 1843634
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Calretinin. A selective marker of normal and neoplastic mesothelial cells in serous effusions.
    Barberis MC; Faleri M; Veronese S; Casadio C; Viale G
    Acta Cytol; 1997; 41(6):1757-61. PubMed ID: 9390137
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Converting fluid-based cytologic specimens to histologic specimens for immunohistochemistry.
    Wallace KA; Goldschmidt MH; Patel RT
    Vet Clin Pathol; 2015 Jun; 44(2):303-9. PubMed ID: 25639814
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lymphocyte subpopulations analysis in pleural fluid and peripheral blood in patients with lymphocytic pleural effusions.
    Albera C; Mabritto I; Ghio P; Scagliotti GV; Pozzi E
    Respiration; 1991; 58(2):65-71. PubMed ID: 1677776
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Relative DNA content and cycle distribution of cells in pleural effusions studied by flow-cytometry].
    Shen C; Ye YQ; Lou WT
    Zhonghua Jie He He Hu Xi Za Zhi; 1994 Apr; 17(2):90-2, 126. PubMed ID: 7994775
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diagnostic utility of MOC-31, HBME-1 and MOC-31 mRNA in distinguishing between carcinoma cells and reactive mesothelial cells in pleural effusions.
    Sun Y; Wu GP; Fang CQ; Liu SL
    Acta Cytol; 2009; 53(6):619-24. PubMed ID: 20014549
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tissue culture studies of malignant effusions.
    Whitehead RH; Hughes LE
    Br J Cancer; 1975 Oct; 32(4):512-8. PubMed ID: 1212414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.